BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$314.94 USD
+4.91 (1.58%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $315.00 +0.06 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/24/24 |
---|---|
Current Quarter | 2.42 |
EPS Last Quarter | 3.11 |
Last EPS Surprise | 46.70% |
ABR | 2.25 |
Earnings ESP
|
-11.80% |
---|---|
Current Year | 10.32 |
Next Year | 11.51 |
EPS (TTM) | 10.83 |
P/E (F1) | 30.52 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 662.81M | 700.52M | 2.59B | 2.78B |
# of Estimates | 2 | 2 | 1 | 2 |
High Estimate | 684.02M | 700.74M | 2.59B | 2.84B |
Low Estimate | 641.60M | 700.30M | 2.59B | 2.72B |
Year ago Sales | 632.12M | 681.18M | 2.67B | 2.59B |
Year over Year Growth Est. | 4.86% | 2.84% | -3.00% | 7.29% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.42 | 3.09 | 10.32 | 11.51 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | 2.70 | 3.39 | 10.41 | 11.46 |
High Estimate | 2.70 | 3.39 | 10.34 | 11.55 |
Low Estimate | 2.13 | 2.78 | 10.30 | 11.47 |
Year ago EPS | 2.33 | 3.10 | 11.78 | 10.32 |
Year over Year Growth Est. | 3.86% | -0.32% | -12.39% | 11.53% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 1 | 1 | 2 | 1 |
Down Last 60 Days | 1 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.42 | 3.09 | 10.32 | 11.51 |
7 Days Ago | 2.42 | 3.09 | 10.36 | 11.51 |
30 Days Ago | 2.84 | 3.58 | 10.80 | 11.75 |
60 Days Ago | 2.84 | 3.58 | 10.80 | 11.75 |
90 Days Ago | 2.80 | 3.47 | 10.42 | 11.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.13 | 2.78 | 10.32 | 11.51 |
Zacks Consensus Estimate | 2.42 | 3.09 | 10.32 | 11.51 |
Earnings ESP | -11.80% | -9.89% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 3.11 | 2.29 | 3.10 | 2.33 | NA |
Estimate | 2.12 | 2.04 | 2.93 | 2.87 | NA |
Difference | 0.99 | 0.25 | 0.17 | -0.54 | 0.22 |
Surprise | 46.70% | 12.25% | 5.80% | -18.82% | 11.48% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more